Ohio State University Comprehensive Cancer Center
🇺🇸United States
Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms
Phase 1
Active, not recruiting
- Conditions
- Essential ThrombocythemiaMyelofibrosisMyeloproliferative NeoplasmPolycythemia VeraSecondary Acute Myeloid Leukemia
- Interventions
- Procedure: Allogeneic Hematopoietic Stem Cell TransplantationDrug: Liposome-encapsulated Daunorubicin-Cytarabine
- First Posted Date
- 2019-03-18
- Last Posted Date
- 2025-04-02
- Target Recruit Count
- 12
- Registration Number
- NCT03878199
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
🇺🇸OHSU, Portland, Oregon, United States
🇺🇸Simmons Cancer Center, Dallas, Texas, United States
Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment
Not Applicable
Completed
- Conditions
- Neuroendocrine CarcinomaSkin CancerGastrointestinal Cancer
- Interventions
- Procedure: Aromatherapy and Essential OilsOther: Subject Diary
- First Posted Date
- 2019-03-01
- Last Posted Date
- 2020-08-04
- Target Recruit Count
- 248
- Registration Number
- NCT03858855
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Papaverine and Stereotactic Body Radiotherapy (SBRT) for Non Small Cell Lung Cancer (NSCLC) or Lung Metastases
Phase 1
Recruiting
- Conditions
- Lung Non-Small Cell Carcinoma
- Interventions
- Procedure: Blood Oxygen Level Dependent ImagingRadiation: Stereotactic Body Radiation Therapy
- First Posted Date
- 2019-01-31
- Last Posted Date
- 2025-02-03
- Target Recruit Count
- 24
- Registration Number
- NCT03824327
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer
Not Applicable
Active, not recruiting
- Conditions
- Anatomic Stage IIIA Breast Cancer AJCC v8Prognostic Stage II Breast Cancer AJCC v8Prognostic Stage IIB Breast Cancer AJCC v8Prognostic Stage III Breast Cancer AJCC v8Prognostic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Prognostic Stage IIIA Breast Cancer AJCC v8
- Interventions
- Radiation: Intensity-Modulated Radiation TherapyRadiation: 3-Dimensional Conformal Radiation Therapy
- First Posted Date
- 2018-12-26
- Last Posted Date
- 2024-04-04
- Target Recruit Count
- 61
- Registration Number
- NCT03786354
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
High Dose Vitamin a in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant
Not Applicable
Recruiting
- Conditions
- Allogeneic Hematopoietic Stem Cell Transplantation Recipient
- Interventions
- Dietary Supplement: Vitamin A Compound
- First Posted Date
- 2018-10-25
- Last Posted Date
- 2025-01-03
- Target Recruit Count
- 130
- Registration Number
- NCT03719092
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Nipple Aspirate Fluid in Detecting Breast Cancer
Not Applicable
Completed
- Conditions
- Anatomic Stage IA Breast Cancer AJCC V8Anatomic Stage IB Breast Cancer AJCC V8Anatomic Stage II Breast Cancer AJCC V8Anatomic Stage IIA Breast Cancer AJCC V8Anatomic Stage IIB Breast Cancer AJCC V8Anatomic Stage III Breast Cancer AJCC V8Anatomic Stage IIIA Breast Cancer AJCC V8Anatomic Stage IIIB Breast Cancer AJCC V8Anatomic Stage IIIC Breast Cancer AJCC V8Anatomic Stage IV Breast Cancer AJCC V8
- Interventions
- Procedure: Aspiration of BreastProcedure: Biospecimen Collection
- First Posted Date
- 2018-10-23
- Last Posted Date
- 2025-02-25
- Target Recruit Count
- 2
- Registration Number
- NCT03715959
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants with Pancreatic Cancer
Not Applicable
Suspended
- Conditions
- Pancreatic CarcinomaPancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type
- Interventions
- Procedure: Optical Coherence TomographyProcedure: Therapeutic Conventional SurgeryDiagnostic Test: Laboratory Evaluation
- First Posted Date
- 2018-10-19
- Last Posted Date
- 2025-03-30
- Target Recruit Count
- 75
- Registration Number
- NCT03711890
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs
Early Phase 1
Recruiting
- Conditions
- Current Every Day SmokerCigarette Smoker
- Interventions
- Procedure: Bronchoscopy with Bronchoalveolar LavageOther: Electronic CigaretteDrug: CigaretteOther: Laboratory Biomarker AnalysisOther: Questionnaire Administration
- First Posted Date
- 2018-10-01
- Last Posted Date
- 2023-10-10
- Target Recruit Count
- 239
- Registration Number
- NCT03691350
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell Lymphoma
Not Applicable
Active, not recruiting
- Conditions
- Diffuse Large B-Cell Lymphoma Germinal Center B-Cell TypeDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedDiffuse Large B-Cell LymphomaHigh Grade B-Cell Lymphoma
- Interventions
- Procedure: Molecular Nanotechnology
- First Posted Date
- 2018-09-04
- Last Posted Date
- 2025-04-16
- Target Recruit Count
- 73
- Registration Number
- NCT03656835
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer
Phase 2
Completed
- Conditions
- Prostate Adenocarcinoma
- Interventions
- Combination Product: Dietary InterventionOther: Questionnaire Administration
- First Posted Date
- 2018-08-31
- Last Posted Date
- 2025-04-04
- Target Recruit Count
- 25
- Registration Number
- NCT03654638
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath